Test to predict pregnancy chances for IVF patients
Official title: Innovation for Small-scale Experiments: ReceptIVFity Test
Run by Erasmus Medical Center · NCT06051201 · Data updated 2026-11-12
This study is testing a new way to predict the chances of getting pregnant through IVF by looking at the vaginal bacteria in women aged 18 to 43.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 42 Years |
| Sex | Women only |
| Enrollment | 683 (estimated) |
| Sponsor | Erasmus Medical Center Academic / other |
| Locations | 1 site (Rotterdam) |
| Status | Recruiting |
| Started | September 4, 2023 |
| Main results expected | September 2026 |
| Study ends | September 2027 |
| Registry record updated | September 19, 2024 |
| Trial ID | NCT06051201 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are naïve IVF or IVF-ICSI patients aged 18 to 43 who are willing to provide a vaginal swab for the ReceptIVFity test.
✕Probably not a fit
Patients currently using hormonal contraceptives or antibiotics, or those requiring emergency IVF for cancer, will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The ReceptIVFity test evaluates the vaginal microbiome to predict the success rate of IVF or IVF-ICSI treatments. This prospective, non-invasive randomized controlled study aims to compare Shared Decision Making with Physician Decision in determining the likelihood of successful pregnancies. It includes an observational arm for women of non-European origin and focuses on naïve IVF patients aged 18 to 43. The study seeks to reduce unnecessary treatment cycles and improve the efficacy of IVF procedures.
Why it matters
Potential benefit: If successful, this test could enhance the chances of achieving pregnancy for IVF patients by providing tailored treatment recommendations.
How similar studies have gone: Other studies have shown promise in using microbiome assessments to improve IVF outcomes, indicating potential success for this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Naïve IVF or IVF/ICSI patients 2. Indication for an IVF or IVF-ICSI procedure. 3. 18 years \< age \< 43 years. 4. Willing to provide a vaginal swab with the ReceptIVFity test. 5. Willing to provide informed consent. Exclusion Criteria: 1. The use of hormonal contraceptives at the time of taking the test. 2. The use of antibiotic treatment at the time of taking the test. 3. Emergency IVF for cancer or other reasons. 4. Women with endometriosis pre-treated with an Gn-RH analogue. 5. Women having IVF for egg preservation reasons.
Where it's running
-
Erasmus University Medical Center
Rotterdam, Netherlands Recruiting
Study contacts
- Principal investigator: Sam Schoenmakers, Dr. drs. — Erasmus MC Rotterdam
- Study coordinator: Xu Shan Gao, drs.
- Email: guvastudie@erasmusmc.nl
- Phone: +31631016348
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Comparing live birth rates in natural cycle embryo transfers with and without hormone support
This study is testing if women can have the same chance of a live birth with a natural embryo transfer without hormone support as they do with hormone support.
-
AI into Ultrasound Diagnostics in Reproductive Medicine
Researchers are testing AI tools that analyze transvaginal ultrasound images to help detect endometriosis, adenomyosis, uterine masses, and pregnancy-related receptivity in women aged 18-45.
-
Prenatal education to reduce environmental exposures during pregnancy
Aimed at pregnant people, this program tests whether a classroom-style education can help reduce exposure to harmful pollutants from seafood and nearby pollution sources.
-
Interprofessional Training to Improve Care for Peri-Delivery Patients with Substance Use Disorder
This program tests INSPIRE, a set of online and in-person trainings for healthcare teams to reduce stigma and improve care for people with substance use disorder around labor, delivery, and postpartum at the University of Utah.
-
Lower-extremity blood pressure monitoring during cesarean under spinal anesthesia
This study tests whether noninvasive blood pressure monitoring from the toe is better than the arm at predicting neonatal outcomes during cesarean delivery with spinal anesthesia.
-
Care4mommies: a compassion-based approach to support moms-to-be
A compassion-based program with pregnancy-specific content is being tested to see if it helps pregnant people build self-compassion and strengthen the bond with their baby.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.